Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064
Condition: Healthy Volunteers, Atopic Diathesis and Atopic Dermatitis Interventions: Drug: LOU064; Drug: Placebo Sponsor: Novartis Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials